Next Article in Journal
Using Species Knowledge to Promote Pro-Environmental Attitudes? The Association among Species Knowledge, Environmental System Knowledge and Attitude towards the Environment in Secondary School Students
Next Article in Special Issue
Effects of Different Dietary Starch Sources and Digestible Lysine Levels on Carcass Traits, Serum Metabolites, Liver Lipid and Breast Muscle Protein Metabolism in Broiler Chickens
Previous Article in Journal
High Dietary Cation and Anion Difference and High-Dose Ascorbic Acid Modify Acid–Base and Antioxidant Balance in Dairy Goats Fed under Tropical Conditions
Previous Article in Special Issue
Influence of Dietary Biosynthesized Zinc Oxide Nanoparticles on Broiler Zinc Uptake, Bone Quality, and Antioxidative Status
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dietary Frankincense (Boswellia serrata) Oil Modulates the Growth, Intestinal Morphology, the Fatty Acid Composition of Breast Muscle, Immune Status, and Immunoexpression of CD3 and CD20 in Broiler Chickens

1
Department of Nutrition and Clinical Nutrition, Veterinary Medicine Faculty, Zagazig University, Zagazig 44511, Egypt
2
Department of Animal Production, Agricultural & Biological Research Division, Center of National Research, Dokki, Cairo 11865, Egypt
3
Biochemistry Department, Animal Health Research Institute (AHRI) (Mansoura Branch) Agriculture Research Center (ARC), Dokki, P.O. Box 246, Giza 12618, Egypt
4
Food Hygiene Department, Animal Health Research Institute (AHRI) (Mansoura Branch) Agriculture Research Center (ARC), Dokki, P.O. Box 246, Giza 12618, Egypt
5
Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
6
Department of Pharmacology, Central Laboratory, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44511, Egypt
7
Department of Histology and Cytology, Veterinary Medicine Faculty, Zagazig University, Zagazig 44511, Egypt
8
School of Science and Engineering, National University of Ireland Galway Republic of Ireland, H91 TK33 Galway, Ireland
*
Author to whom correspondence should be addressed.
Animals 2023, 13(6), 971; https://doi.org/10.3390/ani13060971
Submission received: 23 January 2023 / Revised: 4 March 2023 / Accepted: 6 March 2023 / Published: 7 March 2023
(This article belongs to the Special Issue Precision Feeding and Nutrition in Poultry Production)

Abstract

:

Simple Summary

The expanding knowledge of risks posed by antibiotic resistance in the past decades has led the livestock industry to encourage antibiotic-free production. The search for alternatives to antibiotic growth stimulants has shown a rapid increase. The current work assessed the outcomes of dietary frankincense resin (Boswellia serrata) oil inclusion (0, 200, 400, or 600 mg kg−1 diet) on the performance, carcass traits, the fatty acid content of breast muscle, protein profile, thyroid hormones, and immune status of broiler chickens. The collective outcomes of this experiment suggested that frankincense oil supplementation exerted a positive effect on the growth and intestinal histology of broilers, and enriched the n-3 and n-6 fatty acid content and enhanced their immunity.

Abstract

This investigation explored the impact of dietary frankincense resin oil (FO) on growth performance parameters, intestinal histomorphology, fatty acid composition of the breast muscle, and the immune status of broilers. We allotted 400, three-day-old, male chicks (Ross 308 broiler) into four treatment groups (ten replicates/group; ten chicks/replicate). They were fed a basal diet with different concentrations of FO (0, 200, 400, and 600 mg kg−1). FO supplementation increased the overall body weight (BW) and body weight gain (BWG) by different amounts, linearly improving the feed conversion ratio with the in-supplementation level. Total feed intake (TFI) was not affected. Growth hormones and total serum protein levels also linearly increased with the FO level, while albumin was elevated in the FO600 group. Moreover, total globulins increased linearly in FO400 and FO600 treatment groups. Thyroxin hormone (T3 and T4) levels increased in all FO treatment groups without affecting glucose and leptin serum values. Different concentrations of FO supplementation in the diet increased the activities of Complement 3, lysozyme, and interleukin 10 levels in the serum. Dietary FO in broilers increased the total percentage of n-3 and n-6 fatty acids. It also increased the ratio of n-3 to n-6 linearly and quadratically. Additionally, FO supplementation led to the upregulation of immune clusters of differentiation 3 and 20 (CD3 and CD20) in the spleen, along with improving most of the morphometric measures of the small intestine. In conclusion, FO up to 600 mg kg−1 as a feed additive in broiler chicken production is valuable for promoting their growth, intestinal histomorphology, and immune status along with enriching breast muscle with polyunsaturated fatty acids (PUFA).

1. Introduction

For an extended period, essential oils from aromatic and medicinal plants have been widely employed in poultry production due to their helpful pharmacologically active components and their minimum side effects, as mentioned in the WHO’s recommendations [1,2]. One such compound is Frankincense, which contains numerous biologically active constituents [3]. Frankincense is obtained from the Boswellia genus that belongs to the Burseraceae family. It is an aromatic resin that solidifies to form a yellow–brown granular substance, identified as olibanum [4]. Commercially, it is traded as granules, pellets, or powder [5]. Numerous species of Boswellia have been identified, including Boswellia sacra, B. frereana, B. Serrata (B. thurifera, Indian frankincense), and B. papyrifera. These species produce frankincense oil with different compositions, which largely depend on the geographical source, conditions of harvesting, and climate [6]. Enrichment of poultry diets with frankincense (Boswellia serrata) as a natural product exerted many beneficial effects on productive performance, including increased body weight, the efficiency of feed consumption and absorption, enhanced meat quality, i.e., meat production with low-fat content and no residue, along with increased serum levels of globulin, lymphocyte numbers, and immunity [7].
The principal constituent of frankincense resin is its oil content (60%), which includes monoterpenes (13.1%), sesquiterpenes (1%), and diterpenes (42.5%). FO encourages pancreatic enzyme secretion, increases protein and energy digestibility, and reduces nitrogen, ammonia, and microbial metabolite losses [8]. A decrease in the uric acid level in broilers’ blood by FO suggests high efficiency in protein absorption and lower loss of endogenous protein [7]. FO also exhibits immunostimulatory and antibacterial activity against many gram-positive and gram-negative bacteria [9,10]. Moreover, broilers’ diet supplementation with Frankincense positively influences the microbes (microbiome) in the gastrointestinal tract, increasing the counts of beneficial bacteria Lactobacillus and Enterococcus but decreasing the pH of the digestive tract. During subclinical infection, this reduces microorganisms’ energy and protein consumption in the host, therefore, enhancing growth and minimizing the flux of ammonia and immune intercessor [11,12]. In vitro, Boswellia serrata oil exhibits antimicrobial activities with maximum inhibition zone [13,14,15], antibacterial and antifungal activities [16,17], anti-inflammatory and anti-diarrheal activities associated with anti-cholinergic effects [18], hepatoprotective and antioxidant activities [5,15], and neuroprotective activity [19,20]. It is also helpful for asthma patients as it eases breathing and has a calming effect during cough, cold, and inflammation of bronchus and larynges [21]. These beneficial effects are associated with several antioxidant compounds present in FO, including mono and diterpenes, ethyl acetate, octyl acetate, and methyl anisole [11].
However, there is a lack of studies exploring FO supplementation on broiler performance. Thus, our study determined the effect of FO dietary supplementation on selected performance parameters of broiler diets, such as intestinal histomorphology, the immune status of birds, the fatty acid profile of breast muscle, blood biochemical parameters, and immunoexpression of CD3 and CD20 in the spleen. The study replicated a typical broiler production system within an experimental facility, thus providing a practical basis for interpretation and potential applications.

2. Material and Methods

2.1. Gas Chromatography–Mass Spectrometry (GC-MS) Analysis of FO

Frankincense resin (Boswellia serrata) oil was obtained from Organic Egypt Company (Cairo, Egypt). The active compounds of FO were determined using a Trace GC1310-ISQ Mass Spectrometer (Thermo Scientific, Austin, TX, USA), with a direct capillary column TG–5MS (30 m × 0.25 mm × 0.25 µm film thickness), following the previous description of Amer, et al. [22].

2.2. Birds

The experiments were performed at the Faculty of Veterinary Medicine in the Poultry Research unit, Zagazig University, Egypt. The Ethical approval for the experimental protocol was obtained from the Institutional Animal Care and Use Committee of Zagazig University, Egypt (Approval No. ZU-IACUC/2/F/152/2022).
We obtained 400, one-day-old, Ross 308 broiler chicks from a local hatchery. Chicks were reared in an open, well-ventilated house with sawdust bedding (7 birds/m2). During the first week, the building temperature was set at 34 °C, which was reduced gradually to 25 °C at the end of the experiment. Initially, the illumination regime was set to 23 h light/1 h dark condition and then changed to 20 h light/4 h dark condition until the end of the experiment. Standard health and vaccination programs were implemented against Newcastle and Gumboro diseases. The chicks were monitored daily for any health problems.

2.3. Experimental Design and Diets

On arrival, chicks were exposed to a three-day adaptation period, wherein they were fed a control diet to attain an average initial weight of 99.18 ± 0.14 g. Next, the birds were randomly assigned into four treatment groups (100 chicks each; ten replicates/group; ten chicks/replicate). The experimental groups were as follows: T1 (control group), a basal diet without FO addition (FO0); T2, basal diet + 200 mg FO/kg (FO200); T3, basal diet + 400 mg FO/kg (FO400); T4, basal diet + 600 mg FO/kg (FO600). FO was mechanically mixed with the feed ingredients and offered to the birds in a mashed form. The experiment lasted for 35 days. The feeding period was divided into the following three periods: starter (4th–10th day), grower (11th–23rd day), and finisher periods (24th–35th day). Throughout the experiment, feed and water were added ad libitum. We formulated the ration for each feeding period (starter, grower, and finisher) according to Ross’s manual guide [23], which is illustrated in Table 1.

2.4. Growth Performance

To calculate the average initial BW, birds were weighed individually on their 4th day, and then to determine their BW and BWG; they were reweighed at 10, 23, and 35 days. The feed intake (FI) was calculated as the difference between the amount of feed offered and the amount of feed residue left at the end of each feeding period, which was divided by the number of birds in each replicate. The feed conversion ratio (FCR) was computed as per the following equation:
F C R = F I B W G

2.5. Percentage Calculations of the Dressing, Internal Organs, and Immune Organs

To calculate the percentage of dressing, nine chicks were chosen from each group, weighed, and euthanized using cervical dislocation [24]. The carcasses were plucked, eviscerated, and weighed to determine the carcass weight. The percentage of dressing was determined as follows:
Dressing % = Carcass weight (g)/Live BW (g) × 100.
While the percentages of the internal organs (liver, gizzard, and intestine) and immune organs (spleen and bursa of Fabricius) were determined as follows:
Weights of the organs (g)/the live weight (g) × 100.

2.6. Sampling

For further analyses, three birds were randomly chosen from each replicate (n = 30/group) and euthanized using cervical dislocation [24]. Blood samples (n = 30/group) were collected into sanitized tubes without anticoagulant and were allowed to clot at room temperature. The tubes were then centrifuged at 3500 rpm for 15 min to separate the serum. The separated serum samples were stored at –20 °C until further chemical analysis. Samples from breast muscles (n = 5/group), intestinal samples from the duodenum, jejunum, and ileum (n = 10/group, 2 cm), and spleen samples (n = 10/group) were collected for fatty acid analysis, histomorphological examination, and immunohistochemistry, respectively.

2.7. Fatty Acid Analysis of the Breast Muscle

For the fatty acid analysis, five breast muscle samples (50 g/sample) were collected from each group. A chloroform/methanol (2:1, v/v) solvent method, as described by Belitz et al., was used to extract fat [2].The extracted fatty acids were then measured according to AOAC [25].

2.8. Intestinal Histology and Morphometric Measures

Intestinal specimens were stored in 10% neutral buffered formaldehyde for 72 h and then dehydrated using an ascending grade of ethanol (75–100%). Next, they were treated with xylol I and II and later embedded in paraffin. Finally, the samples were sliced into 4 µm longitudinal and cross-sections using a microtome (Leica RM 2155, England). Slides were stained using Hematoxylin and Eosin (H&E) [26]. The morphometric dimensions were measured as per the description of Amer, et al. [27].

2.9. Blood Biochemical Parameters

The total serum protein level was determined according to the procedures of Grant [28]. The albumin level was assessed according to Doumas, et al. [29]. The serum globulin level was computed by subtracting albumin from total protein values as per Doumas, et al. [30]. The serum glucose value was evaluated using an automatic biochemical analyzer (Robotnik Prietest ECO, India) [31]. The hormones of the thyroid gland (triiodothyronine (T3) and thyroxin (T4)), leptin, and growth hormones (GH) were assessed using chicken ELISA kits (My BioSource Co., San Diego, CA, USA, with Cat. No. MBS269454, MBS265796, MBS025331, and MBS266317, respectively) following the manufacturer’s instructions.

2.10. Immunological Parameters

Interleukin 10 (IL10) was quantified using a specific ELISA assay kit (MyBioSource, San Diego, CA, USA) (Cat. No. MBS701683). C3 level was determined using another ELISA kit (Life Span Biosciences, Inc., Seattle, WA, USA) (Cat. No. LS-F9287). Lysozyme activity was measured as per Lie, et al. [32].

2.11. Immunohistochemical Examination

We carried out immunohistochemical staining for CD3 and CD20 in the spleen tissues according to Saber, et al. [33]. Slides were first treated with mouse anti-chicken CD3, clone CT-3 (Bio-Rad Lab., Dubai, United Arab Emirates), and CD20 (ThermoFisher Scientific, Waltham, MA, USA) and then assessed as per Amer, et al. [27]. The intensity was expressed by the average grayscale [34].

2.12. Statistical Analysis

The data were analyzed using SPSS Version 16 for Windows (SPSS Inc., Chicago, IL, USA). Based on polynomial orthogonal contrasts, one-way ANOVA was applied to calculate linear and quadratic regression equations. The differences between experimental groups were expressed as the mean ± standard deviation (SD) and determined using Duncan’s multiple-range test [35]. The statistical significance of the results was set at (p < 0.05).

3. Results

3.1. Determination of Bioactive Compounds in FO

Table 2 and Figure 1 list the bioactive compounds in FO identified by GC–MS. The main bioactive compounds include farnesol (12.42%), ç-elemene (12.42%), à-farnesene (12.42%), phenol, bis (1,1-dimethylethyl) (7.15%), phenol, 2,4-bis (1,1-dimethylethyl) 2, 4-di-tert-butylphenol (7.15%), phenol, 3,5-bis (1,1-dimethylethyl) (7.15%), 3-thujanol (3.62%), and 10-undecyn-1-ol (3.50%).

3.2. Growth Performance

Table 3 demonstrates the influence of FO supplementation on broilers’ production parameters. In the FO200 group, the BW and BWG were quadratically raised (p = 0.04) throughout the starter period. At different FO concentrations, the FCR decreased linearly (p = 0.04) and quadratically (p = 0.02) with no effect observed on the FI. During the grower period, the BW increased linearly (p = 0.001) and quadratically (p = 0.02), while the BWG (p = 0.001) and FCR (p = 0.002) improved linearly at different FO supplementation levels without any effect on the FI (p > 0.05) as compared to the FO0 treatment. Different concentrations of FO linearly and quadratically increased the BW and BWG. Compared with the FO0 treatment, FO supplementation decreased FCR (p < 0.01) throughout the finisher and overall periods with no effect on the total FI. The final body weight was the highest in the FO200 group and the lowest in the FO0 group (p < 0.05).

3.3. Percentages of the Dressing, Internal Organs, and Immune Organs

FO supplementation at 200, 400, or 600 mg/kg diet showed no linear or quadratic effect on the percentages of dressing, liver, intestine, gizzard, spleen, and bursa of Fabricus compared to the live weight of birds (p > 0.05) (Table 4).

3.4. Fatty Acid Composition of Breast Muscle

Different concentrations of FO Supplementation in broilers linearly increased (p < 0.01) the percentages of α-linolenic acid (18:3 n-3), eicosapentaenoic acid (20:5 n-3), docosapentaenoic acid (22:5 n-3), docosahexaenoic acid (22:6 n-3), and arachidonic acid, with no effect on the percentage of linoleic acid (18:2 n-6). Compared with the FO0 group, all the FO-supplemented groups showed an increase in the total percentage of n-3 (linear p < 0.01, and quadratic p = 0.03) and n-6 fatty acids (linear p < 0.01, quadratic p = 0.01), and also an increased ratio of n-3 to n-6 (linear p < 0.01, quadratic p = 0.04), with the highest percentage shown at 600 mg/kg diet (Table 5).

3.5. Histological Examination

Table 6 and Figure 2 illustrate the effects of FO supplementation on the GIT histology of broilers. While FO200 and FO400 groups showed quadratically increased (p < 0.01) duodenal villus height (VH), FO400 and FO600 groups showed decreased duodenal villus width (VW) (linear p < 0.01 and quadratic p = 0.04). In all experimental groups, duodenal crypt depth (CD) was found to be quadratically increased (p < 0.01). Compared with the FO0 group, muscular coat thickness (MCT) was increased (p < 0.01) in the FO200 and FO400 groups but decreased in the FO600 group. Jejunal VH showed a non-significant increase in the FO200 group and an increase (p < 0.01) in the FO400 and FO600 groups compared with the control (FO0). Therefore, dietary FO supplementation linearly and quadratically increased (p ≤ 0.01) different jejunum morphometric measures (VW, CD, and MCT). Ileal VH was decreased (p < 0.01) in the FO200 and FO600 groups but increased in the FO400 group. FO200, FO400, and FO600 groups showed a linear and quadratic increase in ileal VW and CD. Compared with the control group, ileal MCT increased (p ≤ 0.01) in the FO200 group but decreased in the FO400 group. Routine H&E revealed a moderate number of goblet cells in the duodenum of broilers in FO400 and FO600 (16, 17 cells/HPF, respectively) groups but high numbers in FO0 and FO200 (25, 38 cells/HPF, respectively) groups.

3.6. Serum Biochemical Parameters

The effect of FO supplementation on the biochemical parameters of broilers is presented in Table 7. Different concentration levels of FO supplementation increased the total protein and growth hormone levels in broilers linearly (p < 0.01). Simultaneously, serum albumin showed an increase (p < 0.01) in the FO600 group, with insignificant improvement in other treatment groups. Moreover, total globulins increased linearly (p = 0.001) in the FO400 and FO600 groups, with insignificant improvement in the FO200 group. The T3 and T4 hormones also increased linearly (p < 0.01). These changes were more significant in the FO600 group, followed by the FO400 group. However, glucose and leptin serum levels were not altered (p > 0.05).

3.7. Immunological Parameters

The influence of FO on the immune status of birds is given in Table 8. Compared with the FO0 group, all FO treatments increased the levels of lysozymes, complement 3, and interleukin 10 linearly and quadratically (p ≤ 0.01). The best results were observed at the highest supplementation level (FO600).

3.8. Immunohistochemical Examination

Morphometric analysis of the spleen sections taken from different experimental groups revealed the following average percentage of positive cells (from three high power fields (HPF)) to CD3 T-cell marker: 1.39, 5.34, 15.9, and 26.3 for FO0, FO200, FO400, and FO600 groups, respectively (Figure 3 and Figure 4). Similarly, the average percentage of positive cells (from three high power fields (HPF)) to CD20 B-cell marker exhibited the following values: 17.4, 28.84, 32.61, and 43.25 for FO0, FO200, FO400, and FO600 groups, respectively (Figure 3 and Figure 5).

4. Discussion

The main bioactive compounds identified in FO by GC–MS were farnesol, sesquiterpene constituents, ç-elemene, and α-farnesene along with phenolic compounds, such as bis (1,1-dimethylethyl), phenol,2, 4-bis (1,1-dimethylethyl) 2, 4-di-tert-butylphenol, and phenol, 3, 5-bis (1,1-dimethylethyl). Our results revealed a positive effect of dietary FO supplementation on BWG and FCR of broiler chickens without impacting their feed intake. The most significant results were observed in the group supplemented with 200 mg/kg FO, followed by the group supplemented with 400 mg/kg FO. These inclusive improvements in the growth parameters may be attributed to the following various reasons: (1) the overall good health of birds and improved gastrointestinal tract morphology suggested by an increase in villus height, crypt depth, and absorptive surface area [11,36]; (2) improved absorption of essential nutrients (calcium, phosphorus, and iron) [37]; (3) stimulated activities of gastrointestinal tract enzymes, reduced gas flow, and enhanced gastric juice secretion and flow, leading to increased nutrient digestibility of dry matter and organic matter [38]. Furthermore, the improved growth reported in this study could be due to the increased secretion of growth and thyroid hormones along with improved intestinal histomorphology.
Improved feed efficiency and performance of broilers supplemented with Boswellia serrata (BS) were the results of the better configuration of intestinal villi, gastric microflora, and the overall health of broilers [11,39]. Moreover, BS supplementation in broiler diets at 0.5, 1, and 1.5 g/kg increased their body weight and weight gain linearly; therefore, improving their FCR linearly and quadratically [40]. Previous studies have shown that enriching rabbit diets with 0.25, 0.50, 0.750, and 1.00 g/kg BS improved their BWG and FCR [41]. However, this was in contrast with other researchers who observed a non-significant effect of olibanum (Boswellia thurifera) supplementation at 0.01, 0.015, 0.02, 0.03, or 0.05% and BS resin supplementation at 1.5, 2, or 2.5% on the performance parameters of broilers [36,42]. Moreover, Tabatabaei, et al. [43], reported that during the grower period, broilers supplemented with 0.5% BS exhibited the lowest FCR compared with the control birds.
Our results revealed that supplementation of diets with 200, 400, or 600 mg/kg FO showed no linear or quadratic effect on the percentages of dressing, internal organs, and immune organs’ weight. These findings conferred with the results of Ismail, et al. [41], who confirmed that most traits relating to the composition of rabbit carcass and edible organs were insignificantly affected by diets supplemented with BS. However, our results disagree with that of Mohamed, et al. [40], who reported that supplementing different BS levels to broiler diets improved relative weights of the liver, heart, spleen, bursa, and thymus gland while quadratically increasing the relative weights of gizzard and giblet compared with the control. Moreover, Al-Yasiry, et al. [42] reported good carcass quality of chickens fed with 2.0–2.5% BS-containing diets compared with that of non-treated chickens. The difference between our results and the previous results may be attributed to the form of the additive. While we used BS oil, the previous studies used the whole plant, which definitely differed in composition.
Enriching broiler diets with PUFA leads to improved meat quality [44]. Various research studies have been conducted to change the fatty acid content in poultry meat [45,46]. Enriching broiler diets with herbal extracts and oils has received much attention due to their application in enhancing production parameters and poultry health [47]. In this work, dietary FO supplementation enriched the breast muscle with n-3 PUFA, mainly the α-linolenic acid, eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid, and also n-6 PUFA, particularly the arachidonic acid. It also increased the n-3/n-6 ratio, favoring the acceptance of consumers. The positive effect of FO supplementation on the fatty acid composition of breast muscles may be attributed to different boswellic acids, terpenoids, polyphenols and flavonoids of BS. These can improve the composition of fatty acids, and thereby, the quality of meat [48]. The fatty acid content in broilers’ meat is affected by their diet composition [49] and genetic structure [50]. Our results were in line with the results of previous research in broilers, which demonstrated the positive effect of 1.5, 2, or 2.5% BS resin supplementation on the percentage of PUFA, the sum of total fatty acids, n-3/n-6 saturation, hypocholesterolemic/hypercholesterolemic ratio in breast, abdominal fat, and drumstick muscles in broilers [48]. Furthermore, Nkukwana, et al. [51] showed that diets supplemented with Moringa oleifera leaves increased fatty acids in poultry meat, while broilers fed with Lippia javanica, consisting of the highest terpenes, showed increased levels of oleic acid content in their drumstick muscle [52].
The small intestine in poultry animals is an important gut organ required for nutrient digestion and absorption. In this work, supplementing broilers’ diets with different concentrations of FO increased different morphometric measures of the duodenum and jejunum (VH, VW, CD, and MCT), ileal VW, CD, and MCT. The ileal VH was reduced in the FO200 and FO600 groups but increased in the FO400 group. Lower VH with a linear increase in the VW of the ileum indicated that with the increase in the FO levels, the absorptive surface area also increased, which has the advantage of more nutrient absorption. Moreover, polyphenols and some terpenes decrease extreme oxidative stress by reducing plasma lipid peroxidation [53]. These bioactivities enhance gut health, thus improving the overall health of the animal. Several aromatic plant biostimulants have been reported to enhance intestinal morphology and expression of tight junction proteins, benefiting animals [54,55,56]. BS resin supplementation in broiler diets at 2 or 2.5% levels decreased crypt depth and increased the ratio of villus: crypt without altering VH, while BS levels at 3 and 4% increased duodenal length [54]. Tabatabaei [36], reported that adding different increments of olibanum at 0.01, 0.015, 0.02, 0.03, and 0.05 increased VH and crypt depth of duodenum and jejunum insignificantly but increased ileum VH significantly. The epithelium turnover was positively affected by the increase in intestinal villi height and villus crypt ratio. The reduction in intestinal crypts indicated a decrease in the exchange of enterocytes and also a lower requirement for tissue development [55,56].
Although the experimental data showed no effect of FO supplementation on serum levels of glucose and leptin, an increase was observed in the serum levels of albumin, total globulins, total proteins, thyroxin, and growth hormones. T3 and T4 are produced by the thyroid gland and are essential for regulating many metabolic and feeding processes. They also control the gain rate through several metabolic mechanisms [57]. Higher serum levels of T3 and T4 hormones may result in greater BWG [58]. The anterior pituitary gland’s somatotroph cells secrete growth hormone (GH), which is essential for numerous biological activities. It manages animal growth and the progression of tissue levels [59,60]. The results of growth and thyroid hormones in our study explain the improved growth by FO. A higher globulin level is a valuable index for higher immune response and antibody production [39,61]. Boswellia serrata encourages the function of the thyroid gland, leading to the upregulation of metabolism and an increase in the basal metabolic rate. Our results are consistent with previous results, where the supplementation of BS at 0.5, 1, and 1.5 g/kg increased the globulin level in broilers [40,42]. Additionally, the enrichment of drinking water with different concentrations of Frankincense powder at 0.25, 0.50, 0.75, and 1 g/Liter significantly increased the plasma concentration of total proteins [62]. In contrast to our work, the supplementation of Boswellia serrata resin (BSR) in broiler diets at 1.5, 2, or 2.5% did not alter the values of total serum levels of protein, albumin, and globulins [39]. Another study confirmed that rabbits fed with a BS-enriched diet showed lower albumin levels and A/G ratio compared with the control diet [41].
Our investigation showed an increase in the activities of lysozyme, complement 3, and interleukin 10, with the highest increase observed in the uppermost supplementation level (FO600). Due to its effectiveness and well-established role in the immune process, lysozyme is considered an essential component of non-specific humoral immunity; it has a bactericidal impact and can activate the complement system and phagocytic activity, leading to the destruction of the glycosidic bonds of E.coli and Staphylococcus walls, preventing infection and disease [63]. Lymphocyte subpopulations are identified by specific cell surface biomarkers. After antigen recognition, the T-cell co-receptor CD3 initiates a signaling cascade that activates helper and cytotoxic T cells [64]. A B-lymphocyte surface antigen, CD20, regulates B-cell activity, differentiation, and proliferation [65]. The present study showed that FO supplementation in broiler diets led to significant upregulation of the immunoexpression of CD3 and CD20 genes in the spleen tissue. These results indicate the immunomodulatory effects of FO supplementation in broiler chickens. FO supplementation results in the activation of B- and T-lymphocytes and the production of IgG and IgM antibodies that protect the body from bacterial and viral infection [5,66]. Mikhaeil, et al. [12] performed a lymphocyte proliferation assay and reported an intense immunostimulant activity of FO, which revealed 90% lymphocyte transformation.
Undoubtedly, the immunomodulatory effect of FO is due to its bioactive compound profile. Farnesol, a bioactive compound in FO, has exhibited antibiofilm, fungicidal, antitumor, and anticancer properties [67,68]. Sachivkina, et al. [69] showed that farnesol increased the resistance against yeast-like fungi, suggesting its ability as an antimicrobial compound [70,71,72,73]. Moreover, farnesol stimulates the NF-kB pathway via MEK1/2-ERK1/2-MSK1-dependent phosphorylation of p65, consequently stimulating cytokine production, including IL-6 and IL-1α [74]. Additionally, sesquiterpene constituents, such as c¸-elemene and α-farnesene, exhibit immunomodulatory effects by modulating the anti-inflammatory response through the inhibition of prostaglandin, lipoxygenase, and leukotriene biosynthesis [75]. It is well known that terpenes inhibit bacterial cell division [76] and are quorum sensing (QS) inhibitors. QS is an intracellular bacterial communication system that permits various activities, for example, biofilm formation and expression of virulence factors [77]. Phenol-2, 4-bis (1,1-dimethylethyl) is used as an antioxidant, UV stabilizer, or light protection agent [78,79]. Besides its antimicrobial activity [79,80,81,82], Ren, et al. [78] confirmed that phenol-2, 4-bis (1,1-dimethylethyl) from Pseudomonas fluorescens TL-1 possessed antifungal activity. In ethanol-induced gastric damage models, phenol, 3, 5-bis (1,1-dimethylethyl) and phenol-2, 4-bis (1,1-dimethylethyl) were established to exhibit anti-inflammatory and gastroprotective activities [76].

5. Conclusions

Our results have suggested that supplementing broiler diets with up to 600 mg kg−1 of FO enhances growth performance by stimulating the secretion of growth and thyroid hormones and improving intestinal histomorphology. Dietary FO enhances the birds’ immunity by increasing serum levels of lysozyme, interleukin 10, and complement 3 and also by increasing the expression of the immunolabelling indexes of CD3 and CD20. Dietary FO enriched the breast muscles of birds with n-3 and n-6 PUFA. Thus, FO can be used as a native growth promoter and immune-stimulating agent for broilers. In light of serious issues such as antimicrobial resistance in global animal production, the use of functional feed additives is of paramount interest. Our study on broilers validates the prophylactic benefits of FO in the livestock industry.

Author Contributions

Conceptualization, S.A.A.; formal analysis, A.E.O. and S.A.A.; methodology, S.A.A., A.E.O., A.G., G.K.S., A.H.N., D.E.A., M.S.K., A.-W.A.A.-W., E.M.Y. and S.J.D.; writing—original draft, A.E.O. and S.A.A.; writing—review and editing, S.A.A., A.E.O., A.G., G.K.S., A.H.N., D.E.A., M.S.K., A.-W.A.A.-W., E.M.Y. and S.J.D. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by Zagazig University, Egypt.

Institutional Review Board Statement

The Ethical approval of the experimental protocol was obtained from the Institutional Animal Care and Use Committee of Zagazig University, Egypt (Approval No. ZU-IACUC/2/F/152/2022). All animal experiments were performed based on the recommendations described in “The Guide for the Care and Use of Laboratory Animals in scientific investigations”.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets generated or analyzed during the current study are not publicly available but are available from the corresponding author upon reasonable request.

Acknowledgments

This work was supported by Researchers Supporting project number (RSPD2023R700), King Saud University, Riyadh, Saudi Arabia.

Conflicts of Interest

The authors declare that they have no conflict of interest.

References

  1. Abd El-Hack, M.E.; Alagawany, M. Performance, egg quality, blood profile, immune function, and antioxidant enzyme activities in laying hens fed diets with thyme powder. J. Anim. Feed Sci. 2015, 24, 127–133. [Google Scholar] [CrossRef]
  2. Belitz, H.-D.; Grosch, W.; Schieberle, P. Meat. In Food Chemistry; Springer: Berlin/Heidelberg, Germany, 2009; pp. 563–616. [Google Scholar]
  3. European Commission. European Union Register of Feed Additives Pursuant to Regulation (EC) No 1831/2003; European Commission: Brussels, Belgium, 2014. [Google Scholar]
  4. Afsharypuor, S.; Rahmany, M. Essential oil constituents of two African Olibanums available in Isfahan Commercial Market. Iran. J. Pharm. Sci. 2005, 1, 167–170. [Google Scholar]
  5. Al-Yasiry, A.R.M.; Kiczorowska, B. Frankincense-therapeutic properties. Adv. Hyg. Exp. Med. Postep. Hig. I Med. Dosw. 2016, 70, 380–391. [Google Scholar] [CrossRef] [PubMed]
  6. Yates, R.L.; Wenninger, J.A. Constituents of olibanum oil: Sesquiterpene hydrocarbons. J. Assoc. Off. Anal. Chem. 1970, 53, 941–948. [Google Scholar] [CrossRef]
  7. Al-Yasiry, A.; Kiczorowska, B.; Samolińska, W. Effect of Boswellia serrata resin supplementation on basic chemical and mineral element composition in the muscles and liver of broiler chickens. Biol. Trace Elem. Res. 2017, 179, 294–303. [Google Scholar] [CrossRef]
  8. Yasrib, Q.; Abid, H.; Shashank, K.S.; Ajit, K.S. Potential role of natural molecules in health and disease: Importance of boswellic acid. J. Med. Plants Res. 2010, 4, 2778–2786. [Google Scholar]
  9. Hamidpour, S.; Hamidpour, M.; Shahlari, M.; Hamidpour, R. Chemistry, pharmacology and medicinal property of frankincense (Boswellia species): From the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. Glob. J. Med. Res. 2015, 15, 1–9. [Google Scholar]
  10. Olukemi, M.A.; Kandakai-Olukemi, Y.T.; Mawak, J.D. Antibacterial activity of the stem bark of Boswellia dalzielii. J. Pharm. Bioresour. 2005, 2, 32076. [Google Scholar] [CrossRef]
  11. Kiczorowska, B.; Al-Yasiry, A.; Samolińska, W.; Marek, A.; Pyzik, E. The effect of dietary supplementation of the broiler chicken diet with Boswellia serrata resin on growth performance, digestibility, and gastrointestinal characteristics, morphology, and microbiota. Livest. Sci. 2016, 191, 117–124. [Google Scholar] [CrossRef]
  12. Mikhaeil, B.R.; Maatooq, G.T.; Badria, F.A.; Amer, M.M. Chemistry and immunomodulatory activity of frankincense oil. Z. Nat. C 2003, 58, 230–238. [Google Scholar] [CrossRef]
  13. Ayub, M.A.; Hanif, M.A.; Sarfraz, R.A.; Shahid, M. Biological activity of Boswellia serrata Roxb. oleo gum resin essential oil: Effects of extraction by supercritical carbon dioxide and traditional methods. Int. J. Food Prop. 2018, 21, 808–820. [Google Scholar] [CrossRef]
  14. Sadhasivam, S.; Palanivel, S.; Ghosh, S. Synergistic antimicrobial activity of Boswellia serrata Roxb. ex Colebr. (Burseraceae) essential oil with various azoles against pathogens associated with skin, scalp and nail infections. Lett. Appl. Microbiol. 2016, 63, 495–501. [Google Scholar] [CrossRef]
  15. Montaser, M.M.; El-Sharnouby, M.E.; El-Noubi, G.; El-Shaer, H.M.; Khalil, A.A.; Hassanin, M.; Amer, S.A.; El-Araby, D.A. Boswellia serrata resin extract in diets of Nile tilapia, Oreochromis niloticus: Effects on the growth, health, immune response, and disease resistance to Staphylococcus aureus. Animals 2021, 11, 446. [Google Scholar] [CrossRef]
  16. Camarda, L.; Dayton, T.; Di Stefano, V.; Pitonzo, R.; Schillaci, D. Chemical composition and antimicrobial activity of some oleogum resin essential oils from Boswellia spp. (Burseraceae). Ann. Di Chim. J. Anal. Environ. Cult. Herit. Chem. 2007, 97, 837–844. [Google Scholar]
  17. Gangwal, M.; Vardhan, D. Antifungal studies of volatile constituents of Boswellia serrata. Asian J. Chem. 1995, 7, 675. [Google Scholar]
  18. Etuk, E.; Agaie, B.; Onyeyili, P.; Ottah, C. Toxicological studies of aqueous stem bark extract of Boswellia dalzielii in albino rats. Indian J. Pharmacol. 2006, 38, 359. [Google Scholar] [CrossRef]
  19. Ameen, A.M.; Elkazaz, A.Y.; Mohammad, H.M.; Barakat, B.M. Anti-inflammatory and neuroprotective activity of boswellic acids in rotenone parkinsonian rats. Can. J. Physiol. Pharmacol. 2017, 95, 819–829. [Google Scholar] [CrossRef]
  20. Rajabian, A.; Sadeghnia, H.; Fanoudi, S.; Hosseini, A. Genus Boswellia as a new candidate for neurodegenerative disorders. Iran. J. Basic Med. Sci. 2020, 23, 277. [Google Scholar]
  21. Lawless, J. The Illustrated Encyclopedia of Essential Oils Element Books; Element Books Ltd.: Rockport, MA, USA, 1995. [Google Scholar]
  22. Amer, S.A.; Abdel-Wareth, A.A.; Gouda, A.; Saleh, G.K.; Nassar, A.H.; Sherief, W.R.; Albogami, S.; Shalaby, S.I.; Abdelazim, A.M.; Abomughaid, M.M. Impact of Dietary Lavender Essential Oil on the Growth and Fatty Acid Profile of Breast Muscles, Antioxidant Activity, and Inflammatory Responses in Broiler Chickens. Antioxidants 2022, 11, 1798. [Google Scholar] [CrossRef]
  23. Ross, A. 708 Broiler Nutrition Specification 2014. Available online: http://en.aviagen.com/ross-708/ (accessed on 6 October 2014).
  24. Association, A.V.M. AVMA Guidelines for the Euthanasia of Animals: 2013 Edition; American Veterinary Medical Association: Schaumburg, IL, USA, 2013. [Google Scholar]
  25. AOAC. Official Methods of Analysis of AOAC International; AOAC: Rockville, MD, USA, 2000. [Google Scholar]
  26. Bancroft, J.D.; Gamble, M. Theory and Practice of Histological Techniques; Elsevier Health Sciences: Amsterdam, The Netherlands, 2008. [Google Scholar]
  27. Amer, S.A.; Al-Khalaifah, H.S.; Gouda, A.; Osman, A.; Goda, N.I.; Mohammed, H.A.; Darwish, M.I.; Hassan, A.M.; Mohamed, S.K.A. Potential effects of anthocyanin-rich roselle (Hibiscus sabdariffa L.) extract on the growth, intestinal histomorphology, blood biochemical parameters, and the immune status of broiler chickens. Antioxidants 2022, 11, 544. [Google Scholar] [CrossRef]
  28. Grant, G.H. Amino acids and proteins. In Fundamentals of Clinical Chemistry; Academic Press: Cambridge, MA, USA, 1987. [Google Scholar]
  29. Doumas, B.; Baysa, D.; Carter, R.; Peters, T.; Schaffer, R. Determination of serum total protein. Clin. Chem. 1981, 27, 1642. [Google Scholar] [CrossRef] [PubMed]
  30. Doumas, B.T.; BIGGS, H.G.; ARENDS, R.L.; PINTO, P.V. Determination of serum albumin. In Standard Methods of Clinical Chemistry; Elsevier: Amsterdam, The Netherlands, 1972; Volume 7, pp. 175–188. [Google Scholar]
  31. Trinder, P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 1969, 22, 158–161. [Google Scholar] [CrossRef] [PubMed]
  32. Lie, Ø.; Syed, M.; Solbu, H. Improved agar plate assays of bovine lysozyme and haemolytic complement activity. Acta Vet. Scand. 1986, 27, 23–32. [Google Scholar] [CrossRef] [PubMed]
  33. Saber, S.; Khalil, R.M.; Abdo, W.S.; Nassif, D.; El-Ahwany, E. Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk. Toxicol. Appl. Pharmacol. 2019, 364, 120–132. [Google Scholar] [CrossRef]
  34. Hashish, H.; Kamal, R. Effect of curcumin on the expression of Caspase-3 and Bcl-2 in the spleen of diabetic rats. J. Exp. Clin. Anat. 2015, 14, 18–23. [Google Scholar] [CrossRef]
  35. Duncan, D.B. Multiple range and multiple F tests. Biometrics 1955, 11, 1–42. [Google Scholar] [CrossRef]
  36. Tabatabaei, S.N. Effect of olibanum (Boswellia thurifera) as a feed additive on performance, some blood biochemical and intestinal morphology in broiler chicks. Res. Opin. Anim. Vet. Sci. 2016, 6, 130–134. [Google Scholar]
  37. Gupta, I.; Parihar, A.; Malhotra, P.; Gupta, S.; Lüdtke, R.; Safayhi, H.; Ammon, H.P. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 2001, 67, 391–395. [Google Scholar] [CrossRef]
  38. Krieglstein, C.F.; Anthoni, C.; Rijcken, E.J.; Laukötter, M.; Spiegel, H.-U.; Boden, S.E.; Schweizer, S.; Safayhi, H.; Senninger, N.; Schürmann, G. Acetyl-11-keto-β-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. Int. J. Color. Dis. 2001, 16, 88–95. [Google Scholar] [CrossRef]
  39. Al-Yasiry, A.; Kiczorowska, B.; Samolińska, W.; Kowalczuk-Vasilev, E.; Kowalczyk-Pecka, D. The effect of Boswellia serrata resin diet supplementation on production, hematological, biochemical and immunological parameters in broiler chickens. Animal 2017, 11, 1890–1898. [Google Scholar] [CrossRef]
  40. Mohamed, S.H.; Attia, A.I.; Reda, F.M.; Abd El-Hack, M.E.; Ismail, I.E. Impacts of dietary supplementation of Boswellia serrata on growth, nutrients digestibility, immunity, antioxidant status, carcase traits and caecum microbiota of broilers. Ital. J. Anim. Sci. 2021, 20, 205–214. [Google Scholar] [CrossRef]
  41. Ismail, I.E.; Abdelnour, S.A.; Shehata, S.A.; Abd El-Hack, M.E.; El-Edel, M.A.; Taha, A.E.; Schiavitto, M.; Tufarelli, V. Effect of dietary Boswellia serrata resin on growth performance, blood biochemistry, and cecal microbiota of growing rabbits. Front. Vet. Sci. 2019, 6, 471. [Google Scholar] [CrossRef]
  42. Al-Yasiry, A.R.M.; Kiczorowska, B.; Samolińska, W.; Kowalczuk-Vasilev, E. Growth performance, digestibility, haematology, biochemistry, and some humoral immunity blood parameters of broiler chickens fed different levels of Boswellia serrata resin. Anim. Prod. Sci. 2017, 58, 1885–1891. [Google Scholar] [CrossRef]
  43. Tabatabaei, S.N.; Modaresi, M.; Moatar, F.; Pirestani, A.; Tavalaeean, E. Effect of different levels of Boswellia serrata Triana & Planch on immune responses of broilers chicks. J. Herb. Drugs (Int. J. Med. Herbs) 2012, 3, 49–54. [Google Scholar]
  44. Smet, K.; Raes, K.; Huyghebaert, G.; Haak, L.; Arnouts, S.; De Smet, S. Lipid and protein oxidation of broiler meat as influenced by dietary natural antioxidant supplementation. Poult. Sci. 2008, 87, 1682–1688. [Google Scholar] [CrossRef]
  45. Amer, S.A.; Mohamed, W.A.; Gharib, H.S.; Al-Gabri, N.A.; Gouda, A.; Elabbasy, M.T.; El-Rahman, A.; Ghada, I.; Omar, A.E. Changes in the growth, ileal digestibility, intestinal histology, behavior, fatty acid composition of the breast muscles, and blood biochemical parameters of broiler chickens by dietary inclusion of safflower oil and vitamin C. BMC Vet. Res. 2021, 17, 68. [Google Scholar] [CrossRef]
  46. Kishawy, A.T.; Amer, S.A.; Abd El-Hack, M.E.; Saadeldin, I.M.; Swelum, A.A. The impact of dietary linseed oil and pomegranate peel extract on broiler growth, carcass traits, serum lipid profile, and meat fatty acid, phenol, and flavonoid contents. Asian-Australas. J. Anim. Sci. 2019, 32, 1161. [Google Scholar] [CrossRef]
  47. Dhama, K.; Latheef, S.K.; Mani, S.; Samad, H.A.; Karthik, K.; Tiwari, R.; Khan, R.U.; Alagawany, M.; Farag, M.R.; Alam, G.M. Multiple beneficial applications and modes of action of herbs in poultry health and production-a review. Int. J. Pharmacol. 2015, 11, 152–176. [Google Scholar] [CrossRef]
  48. Kiczorowska, B.; Samolińska, W.; Al-Yasiry, A.; Zając, M. Immunomodulant feed supplement Boswellia serrata to support broiler chickens’ health and dietary and technological meat quality. Poult. Sci. 2020, 99, 1052–1061. [Google Scholar] [CrossRef]
  49. Gou, Z.; Cui, X.; Li, L.; Fan, Q.; Lin, X.; Wang, Y.; Jiang, Z.; Jiang, S. Effects of dietary incorporation of linseed oil with soybean isoflavone on fatty acid profiles and lipid metabolism-related gene expression in breast muscle of chickens. Animal 2020, 14, 2414–2422. [Google Scholar] [CrossRef]
  50. Zanetti, E.; De Marchi, M.; Dalvit, C.; Molette, C.; Rémignon, H.; Cassandro, M. Carcase characteristics and qualitative meat traits of three Italian local chicken breeds. Br. Poult. Sci. 2010, 51, 629–634. [Google Scholar] [CrossRef] [PubMed]
  51. Nkukwana, T.T.; Muchenje, V.; Masika, P.; Hoffman, L.C.; Dzama, K.; Descalzo, A.M. Fatty acid composition and oxidative stability of breast meat from broiler chickens supplemented with Moringa oleifera leaf meal over a period of refrigeration. Food Chem. 2014, 142, 255–261. [Google Scholar] [CrossRef]
  52. Mpofu, D.A.; Marume, U.; Mlambo, V.; Hugo, A. The effects of Lippia javanica dietary inclusion on growth performance, carcass characteristics and fatty acid profiles of broiler chickens. Anim. Nutr. 2016, 2, 160–167. [Google Scholar] [CrossRef] [PubMed]
  53. Qin, S.; Hou, D.-X. The biofunctions of phytochemicals and their applications in farm animals: The Nrf2/Keap1 system as a target. Engineering 2017, 3, 738–752. [Google Scholar] [CrossRef]
  54. Kiczorowska, B.; Samolińska, W.; Al-Yasiry, A.R.M.; Kowalczyk-Pecka, D. Effect of dietary supplementation on growth performance, gastrointestinal microflora, and morphology of broilers. Ann. Anim. Sci. 2016, 16, 835–849. [Google Scholar] [CrossRef]
  55. Pluske, J.R.; Thompson, M.J.; Atwood, C.S.; Bird, P.H.; Williams, I.H.; Hartmann, P.E. Maintenance of villus height and crypt depth, and enhancement of disaccharide digestion and monosaccharide absorption, in piglets fed on cows’ whole milk after weaning. Br. J. Nutr. 1996, 76, 409–422. [Google Scholar] [CrossRef]
  56. Samanya, M.; Yamauchi, K.-e. Histological alterations of intestinal villi in chickens fed dried Bacillus subtilis var. natto. Comp. Biochem. Physiol. Part A Mol. Integr. Physiol. 2002, 133, 95–104. [Google Scholar] [CrossRef]
  57. Oster, M.; Gerlinger, C.; Heide, K.; Just, F.; Borgelt, L.; Wolf, P.; Polley, C.; Vollmar, B.; Muráni, E.; Ponsuksili, S. Lower dietary phosphorus supply in pigs match both animal welfare aspects and resource efficiency. Ambio 2018, 47, 20–29. [Google Scholar] [CrossRef]
  58. Nari, N.; Ghasemi, H.A. Growth performance, nutrient digestibility, bone mineralization, and hormone profile in broilers fed with phosphorus-deficient diets supplemented with butyric acid and Saccharomyces boulardii. Poult. Sci. 2020, 99, 926–935. [Google Scholar] [CrossRef]
  59. Waters, M.J.; Brooks, A.J. Growth hormone and cell growth. Dev. Biol. GH Secret. Growth Treat. 2012, 23, 86–95. [Google Scholar]
  60. Liu, Z.; Cordoba-Chacon, J.; Kineman, R.D.; Cronstein, B.N.; Muzumdar, R.; Gong, Z.; Werner, H.; Yakar, S. Growth hormone control of hepatic lipid metabolism. Diabetes 2016, 65, 3598–3609. [Google Scholar] [CrossRef]
  61. Blas, J.; Scanes, C. Sturkie’s Avian Physiology; Academic Press: Cambridge, MA, USA, 2015. [Google Scholar]
  62. Frankincense, D.L. Effect of supplementation of different levels frankincense to drinking water on certain hematological traits of broiler. Environ. Sci 2013, 8, 589–601. [Google Scholar]
  63. Guo, Y.; Chen, S.; Xia, Z.; Yuan, J. Effects of different types of polyunsaturated fatty acids on immune function and PGE2 synthesis by peripheral blood leukocytes of laying hens. Anim. Feed. Sci. Technol. 2004, 116, 249–258. [Google Scholar] [CrossRef]
  64. Ryan, G. CD3 conformation is crucial for signalling. Nat. Rev. Immunol. 2010, 10, 7. [Google Scholar] [CrossRef]
  65. Tedder, T.F.; Engel, P. CD20: A regulator of cell-cycle progression of B lymphocytes. Immunol. Today 1994, 15, 450–454. [Google Scholar] [CrossRef]
  66. Takagi, Y.; Choi, I.-S.; Yamashita, T.; Nakamura, T.; Suzuki, I.; Hasegawa, T.; Oshima, M.; Gu, Y.-H. Immune activation and radioprotection by propolis. Am. J. Chin. Med. 2005, 33, 231–240. [Google Scholar] [CrossRef]
  67. Paguigan, N.D.; Rivera-Chávez, J.; Stempin, J.J.; Augustinović, M.; Noras, A.I.; Raja, H.A.; Todd, D.A.; Triplett, K.D.; Day, C.; Figueroa, M. Prenylated diresorcinols inhibit bacterial quorum sensing. J. Nat. Prod. 2019, 82, 550–558. [Google Scholar] [CrossRef]
  68. Wang, X.; He, H.; Liu, J.; Xie, S.; Han, J. Inhibiting roles of farnesol and HOG in morphological switching of Candida albicans. Am. J. Transl. Res. 2020, 12, 6988. [Google Scholar]
  69. Sachivkina, N.; Vasilieva, E.; Lenchenko, E.; Kuznetsova, O.; Karamyan, A.; Ibragimova, A.; Zhabo, N.; Molchanova, M. Reduction in pathogenicity in yeast-like fungi by farnesol in quail model. Animals 2022, 12, 489. [Google Scholar] [CrossRef]
  70. Hallen-Adams, H.E.; Suhr, M.J. Fungi in the healthy human gastrointestinal tract. Virulence 2017, 8, 352–358. [Google Scholar] [CrossRef]
  71. Rudenko, P.; Sachivkina, N.; Vatnikov, Y.; Shabunin, S.; Engashev, S.; Kontsevaya, S.; Karamyan, A.; Bokov, D.; Kuznetsova, O.; Vasilieva, E. Role of microorganisms isolated from cows with mastitis in Moscow region in biofilm formation. Vet. World 2021, 14, 40. [Google Scholar] [CrossRef] [PubMed]
  72. Singkum, P.; Muangkaew, W.; Suwanmanee, S.; Pumeesat, P.; Wongsuk, T.; Luplertlop, N. Suppression of the pathogenicity of Candida albicans by the quorum-sensing molecules farnesol and tryptophol. J. Gen. Appl. Microbiol. 2019, 65, 277–283. [Google Scholar] [CrossRef] [PubMed]
  73. Zawrotniak, M.; Wojtalik, K.; Rapala-Kozik, M. Farnesol, a quorum-sensing molecule of Candida albicans triggers the release of neutrophil extracellular traps. Cells 2019, 8, 1611. [Google Scholar] [CrossRef] [PubMed]
  74. Dixon, E.F.; Hall, R.A. Noisy neighbourhoods: Quorum sensing in fungal–polymicrobial infections. Cell. Microbiol. 2015, 17, 1431–1441. [Google Scholar] [CrossRef]
  75. Miguel, M.G. Antioxidant and anti-inflammatory activities of essential oils: A short review. Molecules 2010, 15, 9252–9287. [Google Scholar] [CrossRef]
  76. Schrier, D.; Baragi, V.; Connor, D.; Dyer, R.; Jordan, J.; Imre, K.; Lesch, M.; Mullican, M.; Okonkwo, G.; Conroy, M. The pharmacologic effects of 5-[3, 5-bis (1, 1-dimethylethyl)-4-hydroxyphenyl]-1, 3, 4-thiadiazole-2 (3H)-thione, choline salt (CI-986), a novel inhibitor of arachidonic acid metabolism in models of inflammation, analgesia and gastric irritation. Prostaglandins 1994, 47, 17–30. [Google Scholar] [CrossRef]
  77. Nazzaro, F.; Fratianni, F.; Coppola, R. Quorum sensing and phytochemicals. Int. J. Mol. Sci. 2013, 14, 12607–12619. [Google Scholar] [CrossRef]
  78. Ren, J.; Wang, J.; Karthikeyan, S.; Liu, H.; Cai, J. Natural anti-phytopathogenic fungi compound phenol, 2, 4-bis (1, 1-dimethylethyl) from Pseudomonas fluorescens TL-1. Indian J. Biochem. Biophys. 2019, 56, 162–168. [Google Scholar]
  79. Yoon, M.-A.; Jeong, T.-S.; Park, D.-S.; Xu, M.-Z.; Oh, H.-W.; Song, K.-B.; Lee, W.S.; Park, H.-Y. Antioxidant effects of quinoline alkaloids and 2, 4-di-tert-butylphenol isolated from Scolopendra subspinipes. Biol. Pharm. Bull. 2006, 29, 735–739. [Google Scholar] [CrossRef]
  80. Rangel-Sánchez, G.; Castro-Mercado, E.; García-Pineda, E. Avocado roots treated with salicylic acid produce phenol-2, 4-bis (1, 1-dimethylethyl), a compound with antifungal activity. J. Plant Physiol. 2014, 171, 189–198. [Google Scholar] [CrossRef]
  81. Abdullah, A.-S.H.; Mirghani, M.E.S.; Jamal, P. Antibacterial activity of Malaysian mango kernel. Afr. J. Biotechnol. 2011, 10, 18739–18748. [Google Scholar]
  82. Kumar, P.S.; Duraipandiyan, V.; Ignacimuthu, S. Isolation, screening and partial purification of antimicrobial antibiotics from soil Streptomyces sp. SCA 7. Kaohsiung J. Med. Sci. 2014, 30, 435–446. [Google Scholar] [CrossRef]
Figure 1. Chromatographic Characteristics of FO Compounds.
Figure 1. Chromatographic Characteristics of FO Compounds.
Animals 13 00971 g001
Figure 2. Photomicrograph of the small intestine showing the effect of dietary FO supplementation on different intestinal morphometric measures. VH (green arrows); VW (brown arrows); CD (orange arrows); MCT (black stars). Routine H&E showed a moderate number of goblet cells in FO400 and FO600 groups (16, 17 cells/HPF, respectively) but high numbers in FO0 and FO200 groups (25, 38 cells/HPF, respectively). The FO200 group shows mild villous epithelial stratification with multilayered and proliferated cells having central rounded nuclei and abundant eosinophilic cytoplasm. The normal arrangement of villous cells is seen in other groups. (A,A1), FO0; (B,B1), FO200; (C,C1), FO400; (D,D1), FO600, H&E × 100, 200, respectively.
Figure 2. Photomicrograph of the small intestine showing the effect of dietary FO supplementation on different intestinal morphometric measures. VH (green arrows); VW (brown arrows); CD (orange arrows); MCT (black stars). Routine H&E showed a moderate number of goblet cells in FO400 and FO600 groups (16, 17 cells/HPF, respectively) but high numbers in FO0 and FO200 groups (25, 38 cells/HPF, respectively). The FO200 group shows mild villous epithelial stratification with multilayered and proliferated cells having central rounded nuclei and abundant eosinophilic cytoplasm. The normal arrangement of villous cells is seen in other groups. (A,A1), FO0; (B,B1), FO200; (C,C1), FO400; (D,D1), FO600, H&E × 100, 200, respectively.
Animals 13 00971 g002
Figure 3. Morphometric analyses of immunostained CD3 and CD20 cells in the spleen of broilers from different experimental groups. Means with different superscripts (a,b,c,d) are significant at p < 0.05.
Figure 3. Morphometric analyses of immunostained CD3 and CD20 cells in the spleen of broilers from different experimental groups. Means with different superscripts (a,b,c,d) are significant at p < 0.05.
Animals 13 00971 g003
Figure 4. Immunostaining showing positive (red arrows) and negative (black arrows) CD3 cells in the spleen of broilers from different experimental groups. (A) FO0; (B) FO200; (C) FO400; (D) FO600.
Figure 4. Immunostaining showing positive (red arrows) and negative (black arrows) CD3 cells in the spleen of broilers from different experimental groups. (A) FO0; (B) FO200; (C) FO400; (D) FO600.
Animals 13 00971 g004
Figure 5. Immunostaining showing positive (red arrows) and negative (black arrows) CD20 cells in the spleen of broilers from different experimental groups. (A) FO0; (B) FO200; (C) FO400; (D) FO600.
Figure 5. Immunostaining showing positive (red arrows) and negative (black arrows) CD20 cells in the spleen of broilers from different experimental groups. (A) FO0; (B) FO200; (C) FO400; (D) FO600.
Animals 13 00971 g005
Table 1. Proximate Chemical Composition of the Experimental Diets (%).
Table 1. Proximate Chemical Composition of the Experimental Diets (%).
IngredientsStarter Period
(4–10 d)
Grower Period
(11–23 d)
Finisher Period
(24–35 d)
Yellow corn55.959.362
Corn gluten, 60%3.9355.2756.07
Soybean meal, 48%33.4228.123.825
Soybean oil2.234
Calcium dibasic phosphate1.51.41.3
Calcium carbonate1.21.21.1
Common salt0.150.150.15
DL-methionine, 98%0.40.30.33
Premix *0.30.30.3
Lysine HCl, 78%0.470.450.40
Phytase0.0050.0050.005
Threonine0.10.10.1
Choline0.070.070.07
Antimycotoxin0.10.10.1
Na2CO30.250.250.25
Chemical composition
Crude protein%23.0521.5220.15
ME (Kcal/kg)300431013201
Calcium %0.9410.9040.832
Available phosphorus %0.4810.4480.417
Lysine %1.461.311.16
Methionine %0.7210.6100.626
Threonine %0.8240.7650.713
* Premix per kg of diet: Vit. A, 1500 IU; Vit. E, 10 mg; Vit. D3, 200 IU; Vit. K3, 0.5 mg; thiamine, 1.8 mg; pantothenic acid, 10 mg; riboflavin, 3.6 mg; pyridoxine, 3.5 mg; niacin, 35 mg; folic acid, 0.55 mg; biotin, 0.15 mg; cobalamin, 0.01 mg; Cu, 8 mg; Fe, 80 mg; Mn, 60 mg; Zn, 40 mg; Se, 0.15 mg; I, 0.35 mg.
Table 2. Gas Chromatography–Mass Spectrometry (GC–MS) Analysis of FO.
Table 2. Gas Chromatography–Mass Spectrometry (GC–MS) Analysis of FO.
Bioactive CompoundsRetention TimePeak Area %
Farnesol43.5312.42
ç-Elemene43.5312.42
à-Farnesene43.5312.42
Phenol, bis(1,1-dimethylethyl)17.787.15
Phenol, 2,4-bis(1,1-dimethylethyl) 2,4-di-tert-butylphenol17.787.15
Phenol, 3,5-bis(1,1-dimethylethyl)17.787.15
3-Thujanol30.253.62
Bicyclo [3.1.0] hexan-3-ol, 4-methyl-1-(1-methylethyl)30.253.62
Methyl 11,12-tetradecadienoate30.253.62
10-Undecyn-1-ol30.563.50
(3-Cyclopropylbicyclo [4.1.0] hept-7-Yl)methanol30.563.50
E,E-6,11-Tridecadien-1-ol acetate30.563.50
Bicyclo [4.1.0]heptane,-3-cyclopropyl,-7-hydroxymethyl, trans30.563.50
Dichloroacetic acid, dodec-9-ynyl30.563.50
Table 3. Effects of Dietary FO Supplementation on Growth Performance of Broiler Chickens During the Feeding Periods.
Table 3. Effects of Dietary FO Supplementation on Growth Performance of Broiler Chickens During the Feeding Periods.
Trait MeasuredFO0FO200FO400FO600Regression
LinearQuadratic
Initial BW (g)99.44 ± 0.0199.38 ± 0.6398.75 ± 0.0199.17 ± 0.720.2710.404
Starter period (4–10 days)
BW (g)303.25 ± 24.11 b356.53 ± 14.02 a329.83 ± 15.13 ab335.28 ± 10.01 ab0.1450.04
BWG (g)203.81 ± 24.11 b257.15 ± 14.29 a231.08 ± 15.13 ab236.11 ± 10.66 ab0.1410.04
FI (g)271.85 ± 5.59273.12 ± 7.60258.96 ± 11.39267.08 ± 4.160.1890.462
FCR1.34 ± 0.13 a1.06 ± 0.03 b1.13 ± 0.11 b1.13 ± 0.05 b0.0390.024
Grower period (11–23 days)
BW (g)1073.33 ± 50.07 b1272.00 ± 12.53 a1228.61 ± 55.09 a1289.06 ± 37.52 a0.0010.022
BWG (g)770.08 ± 29.98 b915.47 ± 23.17 a898.78 ± 63.99 a953.78 ± 27.99 a0.0010.08
FI (g)1205.19 ± 29.661216.04 ± 100.871125.21 ± 38.561175.83 ± 29.130.2650.568
FCR1.57 ± 0.03 a1.33 ± 0.15 b1.26 ± 0.12 b1.23 ± 0.01 b0.0020.09
Finisher period (24–35 days)
BW (g)1762.22 ± 56.13 b2209.72 ± 8.67 a2186.11 ± 59.12 a2161.67 ± 88.93 a<0.01<0.01
BWG (g)688.89 ± 13.84 c937.72 ± 21.09 ab957.50 ± 41.89 a872.61 ± 55.19 b<0.01<0.01
FI (g)1487.78 ± 125.591607.08 ± 134.101452.92 ± 53.161455.00 ± 66.140.3620.345
FCR2.16 ± 0.16 a1.71 ± 0.11 b1.52 ± 0.04 b1.67 ± 0.16 b<0.01<0.01
Overall performance
Final BW, g1762.22 ± 56.13 b2209.72 ± 8.67 a2186.11 ± 59.12 a2161.67 ± 88.93 a<0.01<0.01
Total BWG, g1662.78 ± 56.13 b2110.35 ± 8.23 a2087.36 ± 59.12 a2062.50 ± 89.64 a<0.01<0.01
Total FI, g2964.81 ± 159.153096.25 ± 238.202837.08 ± 78.072897.92 ± 58.050.2730.697
FCR1.78 ± 0.04 a1.47 ± 0.11 b1.36 ± 0.03 b1.41 ± 0.07 b<0.01<0.01
a,b,c Means within the same row carrying different superscripts were significantly different at p < 0.05.
Table 4. Effect of FO Supplementation on the Percentages of Dressing, Internal Organs, and Immune Organs (%).
Table 4. Effect of FO Supplementation on the Percentages of Dressing, Internal Organs, and Immune Organs (%).
FO0FO200FO400FO600Regression
LinearQuadratic
Dressing %58.577 ± 0.53 57.573 ± 0.90 57.70 ± 0.35 58.13 ± 0.940.3670.220
Liver %2.66 ± 0.402.47 ± 0.342.38 ± 0.482.44 ± 0.440.5120.620
Spleen %0.13 ± 0.050.10 ± 0.020.12 ± 0.020.15 ± 0.080.6350.302
Intestine %5.43 ± 0.356.06 ± 0.435.91 ± 0.585.21 ± 0.420.5180.05
Gizzard %1.78 ± 0.312.24 ± 0.281.92 ± 0.081.73 ± 0.200.4830.05
Bursa %0.13 ± 0.020.15 ± 0.040.16 ± 0.030.11 ± 0.010.6110.084
Table 5. Effect of FO Supplementation on the Fatty Acid Composition of Breast Muscle.
Table 5. Effect of FO Supplementation on the Fatty Acid Composition of Breast Muscle.
FO0FO200FO400FO600Regression
LinearQuadratic
ALA %0.033 ±0.01 b0.053 ±0.01 a0.056 ±0.01 a0.066 ±0.01 a0.0010.290
EPA %0.026 ±0.01 c0.040 ±0.00 b0.046 ±0.01 b0.050 ±0.01 a<0.010.067
DPA %0.023 ±0.01 b0.040 ±0.01 a0.040 ±0.01 a0.046 ±0.01 a<0.010.067
DHA %0.016 ±0.01 b0.030 ±0.01 a0.036 ±0.01 a0.036 ±0.01 a0.0010.050
LA %0.826 ±0.060.890 ±0.100.863 ±0.010.860 ±0.010.6560.374
AA %1.14 ±0.04 b1.20 ±0.08 b1.28 ±0.01 a1.29 ±0.02 a0.0020.393
n-3 (%).0.096 ±0.02 b0.163 ±0.01a0.176 ±0.02a0.193 ±0.02 a<0.010.03
n-6 (%).1.97 ±0.05 c2.09 ±0.03 b2.15 ±0.01 a2.15 ±0.02 a<0.010.01
n-3: n-6 ratio0.049 ±0.01 b0.078 ±0.002 a0.082 ±0.01 a0.089 ±0.01 a<0.010.04
a,b,c Mean values in the same row with different superscripts differ significantly (p < 0.05). ALA: alphalinolenic acid (18:3 n-3), EPA: eicosapentaenoic acid (20:5 n-3), DPA: docosapentaenoic acid (22:5 n-3), DHA: docosahexaenoic acid (22:6 n-3), LA: linoleic acid (18:2 n-6), AA: arachidonic acid (20:4 n-6), n-3 (% of total fatty acids): omega-3 PUFA, n-6 (% of total fatty acids): omega-6 PUFA.
Table 6. Effect of Dietary FO Supplementation on Intestinal Morphometry.
Table 6. Effect of Dietary FO Supplementation on Intestinal Morphometry.
FO0FO200FO400FO600Regression
LinearQuadratic
Duodenum
VH µm690.68 ± 13.0 c814.78 ± 3.94 a765.07 ± 22.55 b663.11 ± 36.42 c0.05<0.01
VW µm181.57 ± 3.73 a184.47 ± 4.00 a121.82 ± 3.05 c134.42 ± 3.08 b<0.010.043
CD µm140.56 ± 3.24 c183.42 ± 6.60 a150.04 ± 6.39 bc159.67 ± 3.45 b0.110<0.01
MCT µm140.75 ± 2.10 c254.81 ± 10.90 a179.56 ± 5.404 b125.03 ± 2.88 d<0.01<0.01
Jejunum
VH µm811.11 ± 23.5 c862.11 ± 16.3 bc897.38 ± 45.85 b995.43 ± 12.77 a<0.010.180
VW µm115.36 ± 8.48 d266.06 ± 10.62 a158.32 ± 7.06 c247.52 ± 5.66 b<0.01<0.01
CD µm112.76 ± 3.06 c190.68 ± 14.98 a154.90 ± 7.56 b160.45 ± 4.78 b0.002<0.01
MCT µm115.15 ± 3.42 b166.06 ± 6.19 a116.28 ± 2.50 a118.98 ± 2.81 a0.006<0.01
Ileum
VH µm676.29 ± 30.4 b522.81 ± 8.32 c765.23 ± 12.76 a474.49 ± 14.72 d<0.01<0.01
VW µm111.73 ± 3.72 c126.89 ± 10.06 b210.60 ± 7.63 a205.00 ± 6.98 a<0.010.04
CD µm106.89 ± 2.92 c165.94 ± 7.50 a134.92 ± 5.83 b137.26 ± 7.80 b0.006<0.01
MCT µm147.36 ± 2.63 b301.06 ± 29.31 a112.81 ± 2.63 c139.43 ± 4.54 bc0.001<0.01
a,b,c,d Mean values in the same row with different superscripts differ significantly (p < 0.05).
Table 7. Effect of Dietary FO Supplementation on Serum Biochemical Parameters.
Table 7. Effect of Dietary FO Supplementation on Serum Biochemical Parameters.
FO0FO200FO400FO600Regression
LinearQuadratic
Total proteins (g/dL)3.393 ± 0.27 d3.983 ± 0.06 c4.453 ± 0.36 b5.240 ± 0.13 a<0.010.497
Albumin (g/dL)1.250 ± 0.03 b1.347 ± 0.01 b1.730 ± 0.39 ab1.943 ± 0.44 a0.0120.739
Total globulins (g/dL)2.143 ± 0.026 c2.637 ± 0.06 bc2.723 ± 0.06 b3.297 ± 0.51 a0.0010.816
GH (ng/mL)2.73 ± 0.35 c4.03 ± 0.47 b5.00 ± 0.36 a5.23 ± 0.40 a<0.010.050
T3 (ng/mL)3.39 ± 0.17 c4.26 ± 0.06 b4.69 ± 0.36 ab5.10 ± 0.35 a<0.010.176
T4 (ng/mL)19.41 ± 0.21 d21.65 ± 0.91 c23.31 ± 0.89 b25.35 ± 0.79 a<0.010.822
Glucose (mg/dL)336.67 ± 2.08340.33 ± 5.13340.00 ± 3.61341.33 ± 3.060.1840.594
Leptin (ng/mL)2.10 ± 0.061.92 ± 0.241.94 ± 0.192.20 ± 0.040.4400.050
a,b,c,d Mean values in the same row with different superscripts differ significantly (p < 0.05).
Table 8. Effect of Dietary FO Supplementation on the Immune Status of Broiler Chickens.
Table 8. Effect of Dietary FO Supplementation on the Immune Status of Broiler Chickens.
FO0FO200FO400FO600Regression
LinearQuadratic
Lysozyme enzyme (µg/mL)133.00 ±2.65 c172.67 ±14.43 b184.00 ±8.00 ab192.00 ±1.00 a<0.010.011
Complement 3 (g/L)1.063 ±0.02 d1.190 ±0.02 c1.257 ±0.02 b1.293 ±0.02 a<0.010.003
IL10 (ug/mL)1.733 ±0.51 c3.500 ±0.35 b3.967 ±0.21 ab4.400 ±0.26 a<0.010.011
a,b,c,d Mean values in the same row with different superscripts differ significantly (p < 0.05).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Amer, S.A.; Gouda, A.; Saleh, G.K.; Nassar, A.H.; Abdel-Warith, A.-W.A.; Younis, E.M.; Altohamy, D.E.; Kilany, M.S.; Davies, S.J.; Omar, A.E. Dietary Frankincense (Boswellia serrata) Oil Modulates the Growth, Intestinal Morphology, the Fatty Acid Composition of Breast Muscle, Immune Status, and Immunoexpression of CD3 and CD20 in Broiler Chickens. Animals 2023, 13, 971. https://doi.org/10.3390/ani13060971

AMA Style

Amer SA, Gouda A, Saleh GK, Nassar AH, Abdel-Warith A-WA, Younis EM, Altohamy DE, Kilany MS, Davies SJ, Omar AE. Dietary Frankincense (Boswellia serrata) Oil Modulates the Growth, Intestinal Morphology, the Fatty Acid Composition of Breast Muscle, Immune Status, and Immunoexpression of CD3 and CD20 in Broiler Chickens. Animals. 2023; 13(6):971. https://doi.org/10.3390/ani13060971

Chicago/Turabian Style

Amer, Shimaa A., Ahmed Gouda, Gehan K. Saleh, Arwa H. Nassar, Abdel-Wahab A. Abdel-Warith, Elsayed M. Younis, Dalia E. Altohamy, Maha S. Kilany, Simon J. Davies, and Anaam E. Omar. 2023. "Dietary Frankincense (Boswellia serrata) Oil Modulates the Growth, Intestinal Morphology, the Fatty Acid Composition of Breast Muscle, Immune Status, and Immunoexpression of CD3 and CD20 in Broiler Chickens" Animals 13, no. 6: 971. https://doi.org/10.3390/ani13060971

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop